Cheil Bio Co

Cheil Bio Co Liabilities

Delisted·Feb 25, 2026

The The Liabilities of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 2.43 B KRW. In the previous year, The Liabilities was 1.30 B KRW — a change of 87.21% (higher).

Liabilities

2.43 BKRW

YoY

87.21%

Last updated:

In 2023, Cheil Bio Co's total liabilities amounted to 2.43 B KRW, a 87.21% difference from the 1.30 B KRW total liabilities in the previous year.

The Cheil Bio Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2016
3.97 B KRW
Jan 1, 2017
2.47 B KRW
Jan 1, 2018
2.65 B KRW
Jan 1, 2019
3.03 B KRW
Jan 1, 2020
4.43 B KRW
Jan 1, 2021
1.83 B KRW
Jan 1, 2022
1.30 B KRW
Jan 1, 2023
2.43 B KRW
The Cheil Bio Co Liabilities history
YEARLiabilitiesYoY
2.43 BKRW+87.21%
1.30 BKRW-28.99%
1.83 BKRW-58.74%
4.43 BKRW+46.28%
3.03 BKRW+14.42%
2.65 BKRW+7.22%
2.47 BKRW-37.80%
3.97 BKRW-33.69%
5.99 BKRW-8.54%
6.55 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Cheil Bio Co's Liabilities

Cheil Bio Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cheil Bio Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Cheil Bio Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Cheil Bio Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Cheil Bio Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Cheil Bio Co stock

The Liabilities of Cheil Bio Co is 2.43 B KRW in 2023.

The Liabilities of Cheil Bio Co changed from 1.30 B KRW to 2.43 B KRW, representing a 87.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Cheil Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cheil Bio Co

All Key Metrics — Cheil Bio Co